265 related articles for article (PubMed ID: 19543053)
1. Interaction of programmed death-1 and programmed death-1 ligand-1 contributes to testicular immune privilege.
Cheng X; Dai H; Wan N; Moore Y; Vankayalapati R; Dai Z
Transplantation; 2009 Jun; 87(12):1778-86. PubMed ID: 19543053
[TBL] [Abstract][Full Text] [Related]
2. PD-L1/PD-1 signal deficiency promotes allogeneic immune responses and accelerates heart allograft rejection.
Wang W; Carper K; Malone F; Latchman Y; Perkins J; Fu Y; Reyes J; Li W
Transplantation; 2008 Sep; 86(6):836-44. PubMed ID: 18813109
[TBL] [Abstract][Full Text] [Related]
3. Testicular immune privilege promotes transplantation tolerance by altering the balance between memory and regulatory T cells.
Nasr IW; Wang Y; Gao G; Deng S; Diggs L; Rothstein DM; Tellides G; Lakkis FG; Dai Z
J Immunol; 2005 May; 174(10):6161-8. PubMed ID: 15879112
[TBL] [Abstract][Full Text] [Related]
4. Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival.
Gao W; Demirci G; Strom TB; Li XC
Transplantation; 2003 Sep; 76(6):994-9. PubMed ID: 14508368
[TBL] [Abstract][Full Text] [Related]
5. Blockade of the OX40/OX40L pathway and induction of PD-L1 synergistically protects mouse islet allografts from rejection.
Li T; Ma R; Zhu J; Wang F; Huang L; Leng X
Chin Med J (Engl); 2014; 127(14):2686-92. PubMed ID: 25043090
[TBL] [Abstract][Full Text] [Related]
6. Blockade of the interaction between PD-1 and PD-L1 accelerates graft arterial disease in cardiac allografts.
Koga N; Suzuki J; Kosuge H; Haraguchi G; Onai Y; Futamatsu H; Maejima Y; Gotoh R; Saiki H; Tsushima F; Azuma M; Isobe M
Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2057-62. PubMed ID: 15374847
[TBL] [Abstract][Full Text] [Related]
7. Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation.
Kuipers H; Muskens F; Willart M; Hijdra D; van Assema FB; Coyle AJ; Hoogsteden HC; Lambrecht BN
Eur J Immunol; 2006 Sep; 36(9):2472-82. PubMed ID: 16917960
[TBL] [Abstract][Full Text] [Related]
8. Protection of islet allografts transplanted together with Fas ligand expressing testicular allografts.
Takeda Y; Gotoh M; Dono K; Nishihara M; Grochowiecki T; Kimura F; Yoshida T; Ohta Y; Ota H; Ohzato H; Umeshita K; Takeda T; Matsuura N; Sakon M; Kayagaki N; Yagita H; Okumura K; Miyasaka M; Monden M
Diabetologia; 1998 Mar; 41(3):315-21. PubMed ID: 9541172
[TBL] [Abstract][Full Text] [Related]
9. Programmed cell death 1 (PD-1) and its ligand PD-L1 are required for allograft tolerance.
Wang L; Han R; Hancock WW
Eur J Immunol; 2007 Oct; 37(10):2983-90. PubMed ID: 17899549
[TBL] [Abstract][Full Text] [Related]
10. Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism.
Lee I; Wang L; Wells AD; Ye Q; Han R; Dorf ME; Kuziel WA; Rollins BJ; Chen L; Hancock WW
J Immunol; 2003 Dec; 171(12):6929-35. PubMed ID: 14662900
[TBL] [Abstract][Full Text] [Related]
11. Impaired recall of CD8 memory T cells in immunologically privileged tissue.
Dai Z; Nasr IW; Reel M; Deng S; Diggs L; Larsen CP; Rothstein DM; Lakkis FG
J Immunol; 2005 Feb; 174(3):1165-70. PubMed ID: 15661869
[TBL] [Abstract][Full Text] [Related]
12. Transplantation of NIT-1 cells expressing pD-L1 for treatment of streptozotocin-induced diabetes.
Wen X; Zhu H; Li L; Li Y; Wang M; Liu J; Yang D; Liao W; Shen G
Transplantation; 2008 Dec; 86(11):1596-602. PubMed ID: 19077895
[TBL] [Abstract][Full Text] [Related]
13. Roles of programmed death-1 (PD-1)/PD-1 ligands pathway in the development of murine acute myocarditis caused by coxsackievirus B3.
Seko Y; Yagita H; Okumura K; Azuma M; Nagai R
Cardiovasc Res; 2007 Jul; 75(1):158-67. PubMed ID: 17434153
[TBL] [Abstract][Full Text] [Related]
14. Role of the programmed Death-1 pathway in the suppressive activity of alternatively activated macrophages in experimental cysticercosis.
Terrazas LI; Montero D; Terrazas CA; Reyes JL; RodrÃguez-Sosa M
Int J Parasitol; 2005 Nov; 35(13):1349-58. PubMed ID: 16126211
[TBL] [Abstract][Full Text] [Related]
15. Blockade of the PD-1/PD-1L pathway reverses the protective effect of anti-CD40L therapy in a rat to mouse concordant islet xenotransplantation model.
Mai G; del Rio ML; Tian J; Ramirez P; Buhler L; Rodriguez-Barbosa JI
Xenotransplantation; 2007 May; 14(3):243-8. PubMed ID: 17489865
[TBL] [Abstract][Full Text] [Related]
16. PD-1/PD-L1 interactions contribute to functional T-cell impairment in patients who relapse with cancer after allogeneic stem cell transplantation.
Norde WJ; Maas F; Hobo W; Korman A; Quigley M; Kester MG; Hebeda K; Falkenburg JH; Schaap N; de Witte TM; van der Voort R; Dolstra H
Cancer Res; 2011 Aug; 71(15):5111-22. PubMed ID: 21659460
[TBL] [Abstract][Full Text] [Related]
17. PD-L1 Deficiency within Islets Reduces Allograft Survival in Mice.
Ma D; Duan W; Li Y; Wang Z; Li S; Gong N; Chen G; Chen Z; Wan C; Yang J
PLoS One; 2016; 11(3):e0152087. PubMed ID: 26990974
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the programmed death-1/programmed death-1 ligand pathway in CD4+CD25+ regulatory T-cell activity to suppress alloimmune responses.
Kitazawa Y; Fujino M; Wang Q; Kimura H; Azuma M; Kubo M; Abe R; Li XK
Transplantation; 2007 Mar; 83(6):774-82. PubMed ID: 17414712
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of programmed death ligand 1 in dendritic cells inhibits allogeneic lymphocyte activation in mice.
Li W; Wang X; Chen R; Zhu H; Chen G; Sun X
J Surg Res; 2012 Aug; 176(2):e79-87. PubMed ID: 22381170
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumor immunotherapy by blockade of the PD-1/PD-L1 pathway with recombinant human PD-1-IgV.
Zhang C; Wu S; Xue X; Li M; Qin X; Li W; Han W; Zhang Y
Cytotherapy; 2008; 10(7):711-9. PubMed ID: 18841514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]